Heart-smart approaches to diabetes management - Certificate of Completion

Duration

2 hrs

Profession

Specialist

Nurse

Allied Health

# of Credits

4.0

Accreditation

Certificate of Completion

Expiry Date

2020-07-24

Most clinical development programs for diabetes drugs have historically focussed on their glucose-lowering ability with limited cardiovascular safety assessments. This was based on the proven correlation between glycaemic control and microvascular complications on the one hand, with inconclusive data regarding cardiovascular benefits on the other. In some instances, intensive glycaemic control may actually promote negative cardiovascular effects despite improvement of hyperglycaemia. Additionally, in 2008, the thiazolidinedione rosiglitazone was temporarily removed from the US market because of its potential negative impact on cardiovascular disease (CVD) outcomes. Several health authorities subsequently issued a requirement for the assessment of CVD risk for all new diabetes drugs, and several cardiovascular outcome studies have resulted as a consequence. In 2015, the Food and Drug Administration (FDA) removed prescribing and dispensing restrictions on rosiglitazone medicines in light of new data that showed no increasedrisk of heart attack with these drugs compared to metformin and SUs.

This interactive online learning activity is valued at 2 Hour(s) of continuing education.

Associate Professor Michael d'Emden
MBBS, PhD, FRACP
Director of Endocrinology and Diabetes
Royal Brisbane Hospital
Queensland, Australia

Damian Flanagan
MBBS, MWell, DipRACOG
South Coast Medical
Blairgowrie, Victoria, Australia

Après avoir complété ce programme, les participants seront en mesure de :

  • Revoir l’épidémiologie actuelle du virus de la varicelle et du zona (herpès zoster) au Canada et expliquer la nécessité de la vaccination.
  • Passer en revue les données scientifiques sur lesquelles se fonde la posologie optimale et l’efficacité des vaccins contre la varicelle et le zona pour une prévention maximale de la maladie.
  • Conseiller les patients et les soignants à savoir à quel moment et pour quelles personnes la vaccination contre la varicelle et le zona est indiquée.


Related Courses